Copyright
        ©The Author(s) 2022.
    
    
        World J Hepatol. Aug 27, 2022; 14(8): 1562-1575
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1562
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1562
		Figure 1 Receiver operating characteristic curve of the studied miRNAs.
		
			 
		
	
		Figure 2 Survival curve among the studied parameters.
		
			 A: Survival curve in relation to stage; B: Survival curve in relation to response to treatment according to mRECIST; C:  Survival curve in relation to miRNA-326.
		
	
- Citation: Youssef SS, Elfiky A, Nabeel MM, Shousha HI, Elbaz T, Omran D, Marie MS, Elzahry MA, Abul-Fotouh A, Hashem A, Guda MF, Abdelaziz AO. Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians. World J Hepatol 2022; 14(8): 1562-1575
- URL: https://www.wjgnet.com/1948-5182/full/v14/i8/1562.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i8.1562

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                         
                         
			